BlackRock, Inc. 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 13,643,304 5.100% | 2,616,115 (+23.72%) | Filing |
| 2025-04-25 1:00 pm Sale | 2025-03-31 | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 11,027,189 4.900% | -790,191 (-6.69%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 11,817,380 5.300% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | BlackRock Inc. BLK | 11,817,380 5.300% | 11,817,380 (New Position) | Filing |